- Home
- COLL vs IMSR Comparison
COLL vs IMSR Comparison
Compare COLL & IMSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- IMSR
- Stock Information
- Founded
- COLL 2002
- IMSR 2013
- Country
- COLL United States
- IMSR United States
- Employees
- COLL N/A
- IMSR N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- IMSR
- Sector
- COLL Health Care
- IMSR
- Exchange
- COLL Nasdaq
- IMSR Nasdaq
- Market Cap
- COLL 1.1B
- IMSR 1.1B
- IPO Year
- COLL 2015
- IMSR N/A
- Fundamental
- Price
- COLL $45.49
- IMSR $11.33
- Analyst Decision
- COLL Strong Buy
- IMSR
- Analyst Count
- COLL 5
- IMSR 0
- Target Price
- COLL $45.40
- IMSR N/A
- AVG Volume (30 Days)
- COLL 520.4K
- IMSR 2.2M
- Earning Date
- COLL 11-06-2025
- IMSR 01-01-0001
- Dividend Yield
- COLL N/A
- IMSR N/A
- EPS Growth
- COLL N/A
- IMSR N/A
- EPS
- COLL 1.63
- IMSR N/A
- Revenue
- COLL $757,067,000.00
- IMSR $123,320.00
- Revenue This Year
- COLL $21.41
- IMSR N/A
- Revenue Next Year
- COLL $3.28
- IMSR N/A
- P/E Ratio
- COLL $28.29
- IMSR N/A
- Revenue Growth
- COLL 26.34
- IMSR 1234.25
- 52 Week Low
- COLL $23.23
- IMSR $9.99
- 52 Week High
- COLL $48.18
- IMSR $31.50
- Technical
- Relative Strength Index (RSI)
- COLL 74.50
- IMSR N/A
- Support Level
- COLL $35.26
- IMSR N/A
- Resistance Level
- COLL $48.18
- IMSR N/A
- Average True Range (ATR)
- COLL 1.74
- IMSR 0.00
- MACD
- COLL 0.93
- IMSR 0.00
- Stochastic Oscillator
- COLL 80.20
- IMSR 0.00
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About IMSR Terrestrial Energy Inc. Common Stock
Terrestrial Energy Inc is an industry-leading technology company committed to delivering reliable, emission-free, and cost-competitive nuclear energy with a transformative advanced reactor, the Integral Molten Salt Reactor (IMSR). Its mission is to transform global energy markets by commercializing its IMSR Plant, which will deliver low-carbon electricity and industrial heat with superior economics, speed to deployment, and siting flexibility.